首页> 美国卫生研究院文献>Clinical Pharmacology : Advances and Applications >High-dose short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
【2h】

High-dose short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure

机译:大剂量短间隔达托霉素方案对三例慢性肾功能衰竭患者安全且耐受良好

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe recommended daptomycin dosage is 4 or 6 mg/kg/day for the treatment of complicated skin and soft tissue infections or for Staphylococcus aureus bacteremia, endocarditis, and osteomyelitis. Every other day administration is usually recommended for patients with mild to moderate renal impairment. Higher doses (>6 mg/kg/day) have been explored as a possible alternative. Daptomycin is considered a safe anti-methicillin-resistant S. aureus (MRSA) drug, although renal dysfunction may be worsened. In this paper we report on three patients with chronic renal failure who received a higher dose of daptomycin daily for successful treatment for MRSA bacteremia, MRSA osteomyelitis, and methicillin-resistant S. epidermidis (MRSE) endocarditis.
机译:背景达托霉素的推荐剂量为4或6 mg / kg /天,用于治疗复杂的皮肤和软组织感染或金黄色葡萄球菌菌血症,心内膜炎和骨髓炎。通常建议轻度至中度肾功能不全的患者隔天给药。已经探索出更高的剂量(> 6 mg / kg /天)作为可能的替代方法。达托霉素被认为是一种安全的抗甲氧西林金黄色葡萄球菌(MRSA)药物,尽管肾功能不全可能会恶化。在本文中,我们报告了三例慢性肾脏衰竭患者,这些患者每天接受更高剂量的达托霉素用于成功治疗MRSA菌血症,MRSA骨髓炎和耐甲氧西林表皮葡萄球菌(MRSE)心内膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号